Cambridge Investment Research Advisors
IOVA icon

Cambridge Investment Research Advisors’s Iovance Biotherapeutics IOVA Stock Holding History

Cambridge Investment Research Advisors’s Portfolio IOVA Stock Details IOVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$593K Buy
168,869
+130,976
+346% +$419K ﹤0.01% 2647
2025
Q4 		$103K Sell
37,893
-17,364
-31% -$40.2K ﹤0.01% 3698
2025
Q3 		$120K Buy
55,257
+8,308
+18% +$19.6K ﹤0.01% 3577
2025
Q2 		$81K Buy
46,949
+1,072
+2% +$2.67K ﹤0.01% 3492
2025
Q1 		$153K Buy
45,877
+5,237
+13% +$27K ﹤0.01% 3272
2024
Q4 		$301K Sell
40,640
-1,229
-3% -$11.4K ﹤0.01% 2828
2024
Q3 		$393K Buy
41,869
+5,535
+15% +$52.4K ﹤0.01% 2610
2024
Q2 		$291K Buy
36,334
+9,074
+33% +$97.2K ﹤0.01% 2726
2024
Q1 		$404K Buy
+27,260
New +$317K ﹤0.01% 2460

Other funds holding IOVA

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
MFM
MHR Fund Management New York $1.37B AUM 68.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
ICM
Invenomic Capital Management Boston, Massachusetts $2.17B AUM 0.03% 1-Year Est. Return